These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2415198)

  • 41. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics.
    Csernansky JG; King RJ; Faustman WO; Moses JA; Poscher ME; Faull KF
    Br J Psychiatry; 1990 Apr; 156():501-7. PubMed ID: 1696842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
    Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia.
    Ohlund LS; Lindström LH; Ohman A
    J Nerv Ment Dis; 1992 May; 180(5):304-13. PubMed ID: 1374792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
    Kahn RS; Harvey PD; Davidson M; Keefe RS; Apter S; Neale JM; Mohs RC; Davis KL
    Schizophr Res; 1994 Feb; 11(3):217-24. PubMed ID: 7514887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
    Eklundh T; Gunnarsson T; Ornhagen H; Nordin C
    Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aggression and personality: association with amino acids and monoamine metabolites.
    Møller SE; Mortensen EL; Breum L; Alling C; Larsen OG; Bøge-Rasmussen T; Jensen C; Bennicke K
    Psychol Med; 1996 Mar; 26(2):323-31. PubMed ID: 8685288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
    Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
    Nord J Psychiatry; 2011 Apr; 65(2):101-5. PubMed ID: 20662686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
    Jeste DV; Doongaji DR; Linnoila M
    Br J Psychiatry; 1984 Feb; 144():177-80. PubMed ID: 6200172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A critical appraisal of CSF monoamine metabolite studies in schizophrenia.
    Widerlöv E
    Ann N Y Acad Sci; 1988; 537():309-23. PubMed ID: 2462396
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):704-10. PubMed ID: 4210686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.